ライフサイエンスコーパス: serum antibody

1 tional to the titer of MERS-CoV-neutralizing serum antibody.

2 g the potential effect of baseline anti-AAV2 serum antibodies.

3 y consensus peptides recognized by patients' serum antibodies.

4 histochemistry were used to characterize the serum antibodies.

5 and improved the quality of RSV-neutralizing serum antibodies.

6 by multiple effector lymphocyte subsets and serum antibodies.

7 duced elevated pathogen-specific IgM and IgY serum antibodies.

8 s, as they induced similar levels of overall serum antibodies.

9 ected with these pathogens generate specific serum antibodies.

10 eutralization by autologous and heterologous serum antibodies.

11 ently bound to a carrier protein, it elicits serum antibodies.

12 ion developed high titers of GP neutralizing serum antibodies.

13 iated by autologous or heterologous HIV-1(+) serum antibodies.

14 ammation, pathology, cytokine responses, and serum antibodies.

15 espite moderately high levels of preexisting serum antibody, 34 (56%) became infected, of whom 23 (68

16 This concept changed with the discovery of serum antibodies (Ab) against aquaporin-4 (AQP4), which

17 nt with lower and unsustained virus-specific serum antibody (Ab).

18 High-titer serum antibodies against AAV9 only partially blocked CSF

19 None of the patients had serum antibodies against acetylcholine receptors (AChRs)

20 Serum antibodies against commensal microbes were measure

21 As in HIV diagnosis, serum antibodies against FIV classically serve as an ind

22 Naturally induced serum antibodies against human papillomavirus (HPV) may

23 Titers of serum antibodies against keratinocytes and numbers of pe

24 nd quantify the neutralization activities of serum antibodies against LCMV and LASV within a BSL-2 fa

25 ared them to control cohorts for analysis of serum antibodies against M. pneumoniae (n = 479) and Gal

26 20 (9%) of 228 patients had serum antibodies against one or more of the neuronal cel

27 s and found that two specific patterns of 21 serum antibodies against periodontal bacteria were signi

28 Serum antibodies against specific crystallin proteins ar

29 Serum antibodies against the glial potassium channel KIR

30 lso demonstrate a strong association between serum antibodies against the human papillomavirus type 1

31 nearly all children with celiac disease have serum antibodies against tissue transglutaminase (tTG).

32 HLA DQ2/DQ8 and serum antibodies against transglutaminase were analysed.

33 cular samples seems to be more specific than serum antibodies alone.

34 Their serum antibodies and clinical features were studied.

35 , the vaccines elicited RSV F- or G-specific serum antibodies and conferred complete lung protection

36 o significant associations were seen between serum antibodies and cSCC or between betaPV and basal ce

37 sed quantity and quality of RSV-neutralizing serum antibodies and increased protection against wild-t

38 n be targets for ADCC mediated by autologous serum antibodies and innate effector cells.

39 eins, to the induction of HPAIV-neutralizing serum antibodies and protective immunity in chickens.

40 ificant increases were observed in levels of serum antibodies and salivary IgA to influenza A(H3N2) a

41 To identify post-alloHSCT serum antibodies and subsequently B-CLL cell-surface ant

42 se five patients were negative for anti-AAV2 serum antibodies and the fifth had a very low titre (1:1

43 nse to allografts has focused on circulating serum antibodies and the long-lived plasma cells that pr

44 body specificities, we looked for binding of serum antibodies and their effects on potassium channel

45 ntity and higher quality of RSV-neutralizing serum antibodies and was highly protective.

46 either PhtD or PhtE protein generated robust serum antibody and CD4 Th1-biased immune memory and conf

47 enhances systemic helper T cells TH1 and TH2 serum antibody and cytotoxic T-cell levels compared to b

48 LAIV induced strong influenza virus-specific serum antibody and T-cell responses in both naive and in

49 za virus induced potent anti-influenza virus serum antibody and T-cell responses, similar to live vir

50 ermined on the basis of a 4-fold increase in serum antibody and the detection of HCoV by reverse-tran

51 Alveolar bone level, serum antibody, and lymphocyte responses were assessed i

52 lly induced anti-human papilloma virus (HPV) serum antibodies are a likely marker of host immune prot

53 Human serum antibodies are directed at a number of surface pro

54 st whether lymphocytes or rotavirus-specific serum antibodies are essential for resolving antigenemia

55 than the response rate measured by standard serum antibody assays (26.3% and 15.8% by neutralization

56 After sensitization, monkey serum antibody binding and cytotoxicity to RMEC was sign

57 e eRNA vectors induced increased HA-specific serum antibody binding avidity after naked DNA intramusc

58 neutralizing antibodies and higher levels of serum antibody binding to HA1, with stronger avidity and

59 ridization with individual sera to determine serum antibody binding.

60 We concentrate on a recently identified serum antibody biomarker, neuromyelitis optica immunoglo

61 ng HA stalk-specific, broadly cross-reactive serum antibodies by both intramuscular and intranasal ro

62 We tested serum antibodies by indirect immunofluorescence assay.

63 ss has been made using bottom-up analysis of serum antibodies by nanoflow liquid chromatography/high-

64 clinical outcome, we first analyzed NY-ESO-1 serum antibody by ELISA in 144 ipilimumab-treated patien

65 Eastern equine encephalitis diagnostic serum antibody can appear 6 days after the onset of symp

66 onses were assessed by determining the total serum antibody concentration (B(max)), relative affinity

67 protection in this mouse model and that the serum antibody concentration required for protection fro

68 We compared preacquisition serum antibody concentrations to capsular antigens 6B, 7

69 ation is unlikely to be determined by higher serum antibody concentrations to pneumococcal antigens.

70 reinfection, and the presence of NV-specific serum antibodies correlated with protection.

71 ating HSV-2-specific CD8(+) T cells, but not serum antibodies, correlated with reduced viral shedding

72 risk of RVGE given infection, and tested for serum antibody correlates of protection using regression

73 romatography tandem MS proteomic analyses of serum antibodies coupled with next-generation sequencing

74 Based on the serum antibody cross-reactivity data obtained from 14 di

75 esidues L161 to I175, as a primary target of serum antibodies derived from humans who had been treate

76 RECENT FINDINGS: The discovery of serum antibodies directed against ganglioside and glycol

77 since they firmly establish that preexisting serum antibodies directed against residues 161 to 175 on

78 homologous virus challenge in mice, and the serum antibodies directed against the HA head region wer

79 operating characteristic curves to show that serum antibody ELISA, copro-antigen ELISA and faecal egg

80 s determined through an F. hepatica-specific serum antibody enzyme-linked immunosorbent assay (ELISA)

81 e elicited high titres of CN54gp140-specific serum antibodies, equivalent to a systemic vaccination,

82 We have identified serum antibodies from an HIV-infected subject that both

83 Transfer of serum antibodies from DTA-1-treated mice, which contain

84 Murine and human autoantibody clones and serum antibodies from human SLE patients bind to DNASE1L

85 We show that B cells and serum antibodies from inbred mice demonstrate a reproduc

86 were quantitatively screened for binders to serum antibodies from patients with celiac disease (CD),

87 r the identification of the immune target of serum antibodies from patients with inclusion body myosi

88 pplying established ZnT8A assays to purified serum antibodies from patients with type 1 diabetes, we

89 histosoma haematobium adult worm antigens by serum antibodies from schistosome-exposed Zimbabweans ag

90 as being highly and frequently recognized by serum antibodies from seropositive individuals; and (iv)

91 Importantly, post-H1N1 infection serum antibodies from the elderly demonstrated substanti

92 eins were screened for their reactivity with serum antibodies from the mouse model of BA using immuno

93 zation and determined whether the ability of serum antibody from infected monkeys to neutralize SIV w

94 nits of the GABAA receptor showed high titre serum antibodies (>1:160) and CSF antibodies in six pati

95 t hen's egg, as determined based on specific serum antibodies (IgE).

96 tatus and allergic sensitization by specific serum antibodies (immunoglobulin E) against aero-allerge

97 mbinant antigens for their ability to detect serum antibodies in 104 asymptomaticL. donovani-infected

98 uced a high titer of H5N1 HPAIV-neutralizing serum antibodies in all of the immunized monkeys.

99 ced high titers of lethal-toxin-neutralizing serum antibodies in both mice and guinea pigs.

100 the titers of high-quality RSV-neutralizing serum antibodies in hamsters.

101 ing the detection and clinical importance of serum antibodies in patients with various epilepsies and

102 d a high level of HPAIV-specific mucosal and serum antibodies in primates when administered through t

103 aimed to identify autoantigens recognized by serum antibodies in the Rhesus rotavirus (RRV)-induced m

104 om RSV-immunized mice produced no detectable serum antibody in the recipients, nor could these mice i

105 on of probe (e.g. antigen) and analyte (e.g. serum antibody) in a small volume of bodily fluids.

106 As expected, the prevalence and levels of serum antibodies increased with age.

107 To enable discovery of serum antibodies indicative of disease and simultaneousl

108 Thus, prevalent serum antibodies induced by prior infection may not be a

109 Immunized animals induced neutralizing serum antibodies, inhibited virus replication in the lun

110 that the early stage represents diffusion of serum antibodies into the cortical grey matter, whereas

111 What was limited to a few serum antibodies is now complemented with a number of ge

112 rprisingly, passive transfer of neutralizing serum antibody is protective in animal models.

113 mmunoglobulin G1 (IgG1), a subclass of human serum antibodies, is the most widely used scaffold for d

114 er high-dose challenge, as evidenced by high serum antibody levels against Y. pestis F1 antigen.

115 The immunogenicity, including the serum antibody levels and cellular immune responses, and

116 Serum antibody levels and protection from mosquito bite

117 Although Pf-specific serum antibody levels correlated with protection up to 2

118 Hence, this novel biosensor allows assessing serum antibody levels in real time and in un-manipulated

119 ociated with baseline serostatus or baseline serum antibody levels in the cohort.

120 Serum antibody levels peak approximately 5 days after Ft

121 ia during the study exhibited an increase in serum antibody levels that persisted for months after th

122 Serum antibody levels were assessed by means of ELISA.

123 We correlated acute and convalescent serum antibody levels with incidence of recurrent infect

124 (defined as an increase by a factor of 4 in serum antibody levels) was detected in 70% of vaccine re

125 In addition to comparing serum antibody levels, we investigated frequencies of se

126 ry B-cell frequencies to their corresponding serum antibody levels.

127 terations in clonal dominance, and increased serum antibody levels.

128 mma) responses and higher transgene-specific serum antibody levels.

129 Serum antibodies, lung virus titers, weight loss, and pu

130 Specific serum antibodies mediating humoral immunity and autoimmu

131 dramatic effect on the level of neutralizing serum antibodies of all 3 IPV serotypes.

132 Binding of serum antibody of women with EOC or healthy controls to

133 ease, follow-up biopsies, and measurement of serum antibodies on a GFD, biopsy performed on subjects

134 We found significant effects of serum antibodies on proteins of neuroretinal cells espec

135 We investigated serum antibody persistence 3 years after vaccination of

136 Pre-existing serum antibodies play an important role in vaccine-media

137 IgA, was detected in cervical secretions of serum antibody-positive animals, predominantly against M

138 ll populations during infection or decreased serum antibody production, as IL-6 KO mice had similar c

139 the serum and splenic cytokine/chemokine and serum antibody profiles of each mouse strain.

140 Maternal serum antibody protects infants from RSV disease.

141 more, periductal immunoglobulin deposits and serum antibodies reactive to bile duct epithelial protei

142 Serum antibodies reactive with the keratin layer of rat

143 Serum antibody reactive with human stratum corneum found

144 n the human immune response to syphilis, the serum antibody reactivity of syphilitic patients was exa

145 Serum antibody reactivity to this peptide epitope increa

146 We found that (i) serum antibodies recognized an average of 6 ORFs per ser

147 An unexpectedly high fraction of serum antibodies recognized both the H1 and H3 monovalen

148 Serum antibodies recognizing the MCPyV capsid protein VP

149 concentrations of circulating antibodies in serum (antibody repertoire) is a fundamental, yet poorly

150 dies, the molecular composition of the human serum antibody repertoire to an antigen remains unknown.

151 As expected, serum antibody response against influenza A strains were

152 ubcutaneous LVS vaccination induced a robust serum antibody response dominated by IgM, IgG2a, and IgG

153 SAL and alpha2,3SAL and generates a stronger serum antibody response in animals.

154 However, the F-protein-specific serum antibody response in hamsters was increased for th

155 2,3SAL), and a single dose induces a minimal serum antibody response in mice and ferrets.

156 mmunization elicited a stronger neutralizing serum antibody response to laboratory-adapted HIV-1 stra

157 nza A virus (A[H1N1]pdm09) elicited a recall serum antibody response to M2 protein of A(H1N1)pdm09 in

158 ces in immunoglobulin G deposition or in the serum antibody response to oxidized low-density lipoprot

159 The frequency of a serum antibody response was highest among subjects recei

160 M2 did not induce a detectable neutralizing serum antibody response, and inclusion of M2 with HA or

161 nked to a reduced ability to induce a robust serum antibody response.

162 espiratory tract of ferrets and an increased serum antibody response.

163 e nonreducing terminal monosaccharide on the serum antibody response.

164 ate that induces a superior RSV-neutralizing serum antibody response.

165 enzyme-linked immunosorbent assay to measure serum antibody responses against 15 recombinant Candida

166 VA-based vaccines encoding HA induced potent serum antibody responses against homologous H1 or H5 HAs

167 Serum antibody responses against the vaccinating strains

168 nized with the vesicle preparation developed serum antibody responses against vesicle components that

169 administration of adjuvants enhanced anti-P1 serum antibody responses and affected both epitope speci

170 Inactivated rPIV5-H5 primed neutralizing serum antibody responses and controlled H5N1 virus repli

171 5 (ZL46) rapidly induced robust neutralizing serum antibody responses and protected against HPAI chal

172 Bayesian modeling of these TAA-specific serum antibody responses exhibits similar discrimination

173 ted in rapid elicitation of broad and potent serum antibody responses in all four cows.

174 tein (fHbp) have elicited broadly protective serum antibody responses in mice.

175 gainst the 1999 Workshop's postulate of weak serum antibody responses in patients with GAgP and shows

176 itude of influenza virus-specific B-cell and serum antibody responses in relation to virus replicatio

177 mutant strains, we compared cross-protective serum antibody responses of mice immunized with 7 diverg

178 Serum antibody responses peaked at day 7 after the first

179 a multivalent VLP vaccine showed high-titer serum antibody responses that potently cross-neutralized

180 ious RSV generated anti-F and anti-G protein serum antibody responses that were stable over 14 months

181 l 2009 pandemic H1N1 virus, we characterized serum antibody responses to 2009 H1N1 virus in 87 indivi

182 an standard colorimetric ELISA for measuring serum antibody responses to CFA/II and its components, C

183 9 International Workshop postulate of robust serum antibody responses to infecting agents in localize

184 The serum antibody responses to lipopolysaccharide (LPS) ind

185 essed HA vaccine was safe and induced better serum antibody responses to the H3 component when admini

186 Serum antibody responses were assessed by competitive Lu

187 Strong serum antibody responses were detected after a single su

188 Vaccine antigen-specific serum antibody responses were detected in both the intra

189 Serum antibody responses were determined by a hemaggluti

190 Serum antibody responses were determined by means of hem

191 Functional anti-HSV-2 neutralizing serum antibody responses were readily demonstrated in bo

192 IgG ASC and serum antibody responses were relatively low in the youn

193 and duration of virus shedding in stool and serum antibody responses were similar to that observed i

194 ting Env to CD40 gave more robust T cell and serum antibody responses with broader epitope representa

195 bial burden by several species, and selected serum antibody responses).

196 Consistent with the serum antibody responses, RASVs expressing the bla SS-ps

197 d and previously infected animals had robust serum antibody responses, we found key differences in T-

198 d rMV(EZ)EGFP(6) did not induce satisfactory serum antibody responses, whereas both in vitro and in v

199 gG3 comprised the predominant anti-Chlamydia serum antibody responses.

200 additional RSV infections were identified by serum antibody responses.

201 FMP2.1/AS01 elicited anti-AMA1 T-cell and serum antibody responses.

202 of specific immune cells to the airways, and serum antibody responses.

203 two pairs of strains induced high levels of serum antibodies specific for PspA as well as to Salmone

204 All 3 strains induced high levels of serum antibodies specific for PspA as well as to Salmone

205 A general strategy to identify serum antibody specificities associated with a given dis

206 11-200 generates broadly cross-neutralizing serum antibody, suggesting the potential of L2 as a seco

207 earch indicates that gut-microbiota-specific serum antibodies targeting an epitope conserved among Gr

208 these mice led to a decrease in the titer of serum antibodies targeting glucose-6-phosphate isomerase

209 M. genitalium-specific serum antibodies targeting the immunodominant MgpB and M

210 In the pediatric population, elevated serum antibody targeting S. aureus alpha-toxin is correl

211 We tested the accuracy of the JCV serum antibody test by comparing the results of JCV sero

212 HSV-2 and T. pallidum were detected by serum antibody testing.

213 s used included gastrointestinal symptoms or serum antibody tests.

214 es greater stalk-specific and cross-reactive serum antibodies than does vaccination with VSV-vectored

215 meningococcal vaccine candidate that elicits serum antibodies that activate classical complement path

216 Recent studies show that serum antibodies that block HBGA binding correlate with

217 All mice had serum antibodies that labeled the dermal side of salt-sp

218 ccination with UV-EB and rCPAF-UV-EB induced serum antibodies that neutralized chlamydial infectivity

219 on of healthy volunteers induced L2-specific serum antibodies that were detected 1 month after the fi

220 g mTOR activity caused a profound decline in serum antibodies that were specific for exogenous antige

221 hile there was some initial reduction in the serum antibodies, the spinal fluid antibodies remained p

222 ndent on maintenance of an adequate level of serum antibody through early childhood.

223 olyplexes not only induced multi-fold higher serum antibody titer in comparison to all other formulat

224 ain reaction (RT-PCR) or a >/=4-fold rise in serum antibody titer measured by hemagglutination inhibi

225 us and diphtheria as defined by a protective serum antibody titer of >/=0.01 IU/mL.

226 ry end point (virus isolation or increase in serum antibody titer).

227 nalysis to evaluate the relationship between serum antibody titers against 19 selected oral microorga

228 Adjuvanted vaccines stimulated robust serum antibody titers against HA and neuraminidase compa

229 djuvant, the fusion conjugate induced higher serum antibody titers and greater priming for IL-17A res

230 ant in determining systemic immunity such as serum antibody titers and memory CD8(+) T cells in the s

231 ptive immune response was evaluated based on serum antibody titers and production of T cell-derived c

232 The HRV dose increases antirotavirus serum antibody titers and the proportion of infants with

233 loss, with a reduction in anti-P. gingivalis serum antibody titers compared with wild-type infected c

234 n, evidenced by high anti-nucleoprotein (NP) serum antibody titers early, while there is still active

235 MF59 enhanced the magnitude and kinetics of serum antibody titers following vaccination, and induced

236 We performed cross-sectional analysis of serum antibody titers in 546 adult subjects stratified b

237 8- and 30-fold increases of RSV-neutralizing serum antibody titers in the presence and absence of add

238 Neutralizing serum antibody titers of >15 correlated with protection

239 e-N position elicited higher GP neutralizing serum antibody titers than the N-P viruses, and unmodifi

240 We also observed markedly reduced serum antibody titers to GD3, which may allow for a popu

241 Serum antibody titers to vaccine-related antigens were m

242 immunized mice elicited significantly higher serum antibody titers toward EBGP or its mutants, as det

243 Antibody-secreting cells (ASC) and serum antibody titers were assessed.

244 Serum antibody titers were comparable across regimens an

245 Whole-cell inclusion immunofluorescence serum antibody titers were recorded among infertile wome

246 decreased pulmonary inflammation, increased serum antibody titers, and lower levels of gamma interfe

247 Despite a decline in stalk-specific serum antibody titers, sequential sH1N1 influenza virus-

248 es consisting of killed bacteria induce high serum antibody titers, they do not always confer protect

249 ad persistently high cerebrospinal fluid and serum antibody titers, which may be of prognostic signif

250 and transgenic expression of BCL2 increased serum antibody titers.

251 by virus detection and/or >/=4-fold rise in serum antibody titers.

252 sting of stool samples or 4-fold increase in serum antibody titers.

253 mprovement was associated with a decrease of serum antibody titres.

254 with generalized myasthenia gravis (MG) have serum antibodies to acetylcholine receptor [AChR; acetyl

255 h allow the parallel measurement of multiple serum antibodies to autoantigens and peptides.

256 a cutoff of three SD above the control mean, serum antibodies to D2R or NR1 were detected in 8 of 43

257 can be identified based on the detection of serum antibodies to deamidated gliadin peptides (DGPs).

258 Serum antibodies to H. pylori in general and the cytotox

259 SP60 and the quantities and specificities of serum antibodies to HSP60 provide a biomarker to monitor

260 Volunteers with no measurable serum antibodies to influenza A/Wisconsin/67/2005 receiv

261 combined data sets indicated the presence of serum antibodies to KIR4.1 in 186 of 397 persons with mu

262 Serum antibodies to Msgs are important markers of P. jir

263 ponses were detected in both groups, whereas serum antibodies to MVA were only detectable after intra

264 d by oxidative stress and that the levels of serum antibodies to oral bacteria might be an intermedia

265 of the mice in which arthritis resolved, had serum antibodies to outer surface protein A of B burgdor

266 Serum antibodies to pandemic H1N1 NA were observed in al

267 es, these results suggest that pretransplant serum antibodies to peroxisomal-trans-2-enoyl-coA-reduct

268 ent in glaucoma includes increased titers of serum antibodies to retina and optic nerve proteins, alt

269 This is the first report of serum antibodies to surface D2R and NR1 in pediatric pat

270 trong correlation between the sensitivity of serum antibodies to the maturation state of DENV and cel

271 We measured serum antibodies to the neuraminidase (NA) of pandemic H

272 -phase or nonneutralizing rotavirus-specific serum antibodies to the systemic compartment of severe-c

273 us sites of the DNA construct deposition and serum antibodies to these lipoproteins.

274 ndicates that <5% patients with sCJD develop serum antibodies to these neuronal antigens and, when po

275 with modified PfEMP1 expression to quantify serum antibodies to VSAs among individuals exposed to ma

276 ed using DNA checkerboard hybridization, and serum antibody to a battery of oral microorganisms was d

277 A low level of serum antibody to antigens expressed by Streptococcus pn

278 also have myelitis (neuromyelitis optica) a serum antibody to aquaporin-4 water channels has been de

279 Serum antibody to Campylobacter rectus was elevated in t

280 Infant immunity was defined by presence of serum antibody to hepatitis B surface antigen among chil

281 Significant differences in serum antibody to multiple oral bacteria were found in a

282 Serum antibody to p53 and HOXB7 is positively associated

283 HIV-1 gp140 induced extraordinary titers of serum antibody to the 2F5 ELDKWA epitope but little or n

284 Serum antibody to the hemagglutinin (HA) of influenza vi

285 Serum antibody to the pH1N1 and seasonal A/H1N1 viruses

286 ntly, the avidity of tetanus toxoid-specific serum antibodies was substantially lower in these subjec

287 Serum antibody was measured before vaccination and 28 an

288 ASC trafficking to bone marrow nor antiviral serum antibody was reduced relative to levels in control

289 Serum antibodies were detected in 21/48 (44%) patients:

290 NA hybridization analysis, and corresponding serum antibodies were determined by ELISA.

291 -propionate receptors (AMPA-R) (GluR1/GluR2) serum antibodies were determined.

292 The results showed that the majority of serum antibodies were directed to the E1 region 211 to 2

293 Serum antibodies were measured and evaluated for 36 cuta

294 Immunoglobulin M and/or G borrelial serum antibodies were present in 72 patients (50%).

295 as completely cleared from nasal samples and serum antibodies were still undetectable.

296 In mice, the chimeric vaccines elicited serum antibodies with bactericidal activity against a pa

297 of Pfs25-CP VLPs plus Alhydrogel(R) induced serum antibodies with complete transmission blocking act

298 id assay detected HIV and Treponema pallidum serum antibodies with sensitivities of 100% (95% confide

299 NA induced high titers of HPAIV-neutralizing serum antibodies, with the response to HA being greater,

300 nes confer protection via the elicitation of serum antibodies, yet more than 100 y after the discover